MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1365-2710.2010.01234.x

Медицинская библиотека · Journal of clinical pharmacy and therapeutics · 2010

Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease.

Horai Y, Miyamura T, Shimada K, Takahama S, Minami R, Yamamoto M, Suematsu E

Клинический случайСтатьяОбзорПеревод в очереди

Аннотация

WHAT IS KNOWN AND

OBJECTIVE

Tumour necrosis factor-α (TNF-α)-blocking agents are increasingly used in the management of refractory rheumatoid arthritis (RA). Although effective, they are associated with rare but potentially fatal adverse effects, including interstitial lung disease (ILD). In patients with pre-existing ILD, eternacept (ETN) monotherapy is often regarded as a suitable choice. Other anti-TNF-α blockers such as infliximab and adalimumab, are used in combination therapy with methotrexate (MTX) in most of the cases. We report on a case of fatal exacerbation of ILD in a patient given ETN monotherapy and review the literature on ETN-associated ILD.

METHODS

We report on a case of a 75-year-old male with RA who developed severe ILD after the introduction of ETN, and we undertook a literature search to identify other reports of similar cases. We then critically assessed those reports.

RESULTS AND DISCUSSION: In addition to our case, 11 other patients have been reported to have developed ILD in association with the use of ETN. Six patients had pre-existing ILD. Although four patients received MTX, eight patients developed severe ILD without MTX. Ten patients recovered after termination of ETN, although two patients died.

WHAT IS NEW AND

CONCLUSION

Although ETN is often regarded as safe for patients with ILD, our case and the literature reports suggest that caution is still required.

Для цитирования: Horai Y, Miyamura T, Shimada K, Takahama S, Minami R, Yamamoto M, Suematsu E. Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease.. Journal of clinical pharmacy and therapeutics. 2010. DOI: 10.1111/j.1365-2710.2010.01234.x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.